Cytek will host a conference call to discuss its fourth quarter and year end 2024 financial results on Thursday, February 27, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A webcast of the ...

Annexon Biosciences, Inc. ( ($ANNX) ) has released its Q4 earnings. Here is a breakdown of the information Annexon Biosciences, Inc. presented to ...

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE ...

Research and Development (R&D) expenses: R&D expenses were $24.8 million for the fourth quarter of 2024, compared to $42.0 million for the fourth quarter of 2023. R&D expenses were $117.0 million for ...

Pacira (($PCRX)) has held its Q4 earnings call. Read on for the main highlights of the call. Pacira BioSciences’ recent earnings call painted a ...

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, Ratings reports. One investment ...

Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price target upped by HC Wainwright from $57.00 to $70.00 in a report ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...

ByInvesting.com • Mar 04, 2024 Cellectar Biosciences Reports High Rate of Complete Remission in Phase I Study of Iopofosine with External Beam Radiotherapy Cellectar Biosciences, Inc. (NASDAQ ...

Cytek Biosciences Inc (NASDAQ:CTKB) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $59.38 million, and the earnings are expected to come in at $0 ...

Before you invest in Avidity Biosciences, Inc. (RNA), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.